In conclusion, we demonstrated that the excessive expression of FOXP3 in tumor-infiltrating CD4+ T cells of CRC patients is caused, at least in part, by the upregulation of STAT5 and TET2. The gene discussed is FOXP3; the disease is colorectal carcinoma.